EUFEMED, 3rd Annual Conference, 28-30 April 2021

Event Date:
28-30 April 2021
Location:
Virtual Meeting
View ProgramView Program

The EUFEMED conference spotlights exploratory development of novel therapeutic approaches – lessons learned in the pandemic. Join regulators, sponsors and CROs to hear how the industry has overcome the challenge of conducting clinical research during a global pandemic.

Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.

Join the conversation and register on the EUFEMED website.

You can read how Richmond Pharmacology responded to the pandemic in our article in PM Live.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Making gains in drug development

September 2, 2021
Keith Berelowitz outlines the innovations in the design and delivery of clinical trials
Read more

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

September 2, 2021
This novel therapeutic drug has potential to impact millions at risk of heart attack and stroke.
Read more

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more